表紙
市場調查報告書

心臟定位的全球市場 ∼2024年:接觸式式 (電解剖圖、Basket導管定位)、非接觸式

Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 922742
出版日期 內容資訊 英文 137 Pages
訂單完成後即時交付
價格
心臟定位的全球市場 ∼2024年:接觸式式 (電解剖圖、Basket導管定位)、非接觸式 Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024
出版日期: 2020年01月15日內容資訊: 英文 137 Pages
簡介

全球心臟定位的市場在預測期間內預計將以8.7%的年複合成長率 (CAGR) 發展,從2019年的14億美元,成長到2024年21億美元的規模。新加入經營者的崛起,投資、資金、津貼的擴大,標的疾病的罹患率增加,老年人口的增加等要素促進該市場成長。可是同時,在美國不利的醫療改革,經驗豐富的電生理學技術的專家不足等課題有抑制市場進一步成長的可能性。

本報告提供全球心臟定位的市場調查,市場定義和概要,對市場成長的各種影響因素及市場機會分析,各類型、適應症、地區/主要國家趨勢與市場規模的變化、預測,競爭環境,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 重要考察

第5章 市場概要、產業趨勢

  • 簡介
  • 宏觀指標
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 心臟定位系統市場分析、預測:各類型

  • 簡介
  • 接觸式
    • 電解剖圖系統
    • Basket導管定位系統
    • 傳統心內膜接觸式定位系統
  • 非接觸式

第7章 心臟定位系統市場分析、預測:各適應症

  • 簡介
  • 心房纖維顫動
  • 心房纖維顫動
  • AVNRT (房室結迴旋性心搏過速)
  • 其他心律不整

第8章 心臟定位系統市場分析、預測:各地區、主要國家

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第9章 競爭環境

  • 簡介
  • 市場排行榜
  • 競爭領導定位
  • 競爭模式

第10章 企業簡介

  • BIOSENSE WEBSTER, INC. (JOHNSON & JOHNSON)
  • ABBOTT LABORATORIES
  • BOSTON SCIENTIFIC CORPORATION
  • MEDTRONIC PLC
  • MICROPORT SCIENTIFIC CORPORATION
  • EP SOLUTIONS SA
  • ACUTUS MEDICAL
  • KONINKLIJKE PHILIPS N.V.
  • LEPU MEDICAL
  • BIOTRONIK
  • ANGIODYNAMICS
  • BIOSIG TECHNOLOGIES, INC.
  • APN HEALTH, LLC
  • COREMAP
  • KARDIUM, INC.
  • CATHETER PRECISION, INC.
  • EPMAP-SYSTEM

第11章 附錄

目錄
Product Code: MD 7502

"The cardiac mapping market is projected to grow at a CAGR of 8.7% during the forecast period."

The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%. The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.

"The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period."

The cardiac mapping products market has been segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.

"The atrial fibrillation applications segment held the largest market share in 2018."

By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.

"The North American cardiac mapping market is expected to hold the largest share during the forecast period."

Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 50%, Tier 2 - 30%, and Tier 3 - 20%
  • By Designation: C-level - 37%, Director-level - 29%, and Others - 34%
  • By Region: North America - 35%, Europe - 30%, APAC - 25%, and RoW - 10%

The major players in the cardiac mapping market include: Biosense Webster (US), Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

Research Coverage:

This report studies the cardiac mapping market based on product, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments for four main regions and respective countries.

Key Benefits of Buying the Report:

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cardiac mapping market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
  • 2.2. RESEARCH METHODOLOGY STEPS
    • 2.2.1. SECONDARY DATA
      • 2.2.1.1. Secondary sources
    • 2.2.2. PRIMARY DATA
      • 2.2.2.1. Key insights from primary sources
    • 2.2.3. MARKET SIZE ESTIMATION METHODOLOGY
    • 2.2.4. REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.3. MARKET DATA ESTIMATION AND TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CARDIAC MAPPING SYSTEMS MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: EUROPEAN CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION & COUNTRY (2019)
  • 4.3. CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019 VS. 2024
  • 4.4. CARDIAC MAPPING SYSTEMS MARKET SHARE, BY INDICATION, 2019 VS. 2024
  • 4.5. GEOGRAPHIC OUTLOOK: CARDIAC MAPPING SYSTEMS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. New entrants in the market
      • 5.2.1.2. Growing investments, funds, and grants
      • 5.2.1.3. Increasing incidence of target diseases
      • 5.2.1.4. Growth in the geriatric population
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Unfavorable healthcare reforms in the US
      • 5.2.2.2. Lack of skilled and experienced electrophysiologists
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Technological advancements
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Unfavorable regulatory scenario
      • 5.2.4.2. Alternative technologies

6. CARDIAC MAPPING SYSTEMS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. CONTACT CARDIAC MAPPING SYSTEMS
    • 6.2.1. ELECTROANATOMICAL MAPPING SYSTEMS
      • 6.2.1.1. Electroanatomical mapping systems account for the largest share of the contact cardiac mapping systems market
    • 6.2.2. BASKET CATHETER MAPPING SYSTEMS
      • 6.2.2.1. Basket catheter mapping systems provide simultaneous, multiple, stable recordings for most endocardial surfaces- a key factor driving market growth
    • 6.2.3. TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS
      • 6.2.3.1. Exposure to ionizing radiation due to the need for fluoroscopy guidance is a key disadvantage of traditional endocardial contact mapping systems
  • 6.3. NON-CONTACT CARDIAC MAPPING SYSTEMS
    • 6.3.1. ADVANTAGE OF NON-CONTACT CARDIAC MAPPING IN CASES WHERE THE ARRHYTHMIA CANNOT BE TOLERATED OR WHERE CLINICAL ARRHYTHMIA IS NOT REPRODUCIBLE-A KEY DRIVER

7. CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION

  • 7.1. INTRODUCTION
  • 7.2. ATRIAL FIBRILLATION
    • 7.2.1. GROWING NUMBER OF ATRIAL FIBRILLATION CASES AND THE SUBSEQUENT INCREASE IN THE NUMBER OF ABLATION PROCEDURES TO DRIVE MARKET GROWTH
  • 7.3. ATRIAL FLUTTER
    • 7.3.1. HIGH SUCCESS RATE OF RADIOFREQUENCY CATHETER ABLATION FOR THE TREATMENT OF ATRIAL FLUTTER IS A MAJOR FACTOR CONTRIBUTING TO THE GROWTH OF THIS MARKET
  • 7.4. ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA (AVNRT)
    • 7.4.1. GROWING NUMBER OF AVNRT CASES ACROSS THE GLOBE IS SUPPORTING THE GROWTH OF THIS SEGMENT
  • 7.5. OTHER ARRHYTHMIAS

8. CARDIAC MAPPING SYSTEMS MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. US
      • 8.2.1.1. High burden of CVDs to drive the demand for cardiac mapping systems in the US
    • 8.2.2. CANADA
      • 8.2.2.1. Growing focus of government organizations on providing research funding to support market growth in Canada
  • 8.3. EUROPE
    • 8.3.1. GERMANY
      • 8.3.1.1. Favorable healthcare expenditure and growing use of CRT devices to drive market growth
    • 8.3.2. UK
      • 8.3.2.1. Growing geriatric population to support market growth
    • 8.3.3. FRANCE
      • 8.3.3.1. Increasing incidence of heart failure to support market growth
    • 8.3.4. ITALY
      • 8.3.4.1. Increasing incidence of CVD to drive the adoption of cardiac mapping systems
    • 8.3.5. SPAIN
      • 8.3.5.1. Growing number of cardiac ablation procedures to drive the market in Spain
    • 8.3.6. REST OF EUROPE
  • 8.4. ASIA PACIFIC
    • 8.4.1. JAPAN
      • 8.4.1.1. Favorable reimbursement scenario to support market growth
    • 8.4.2. CHINA
      • 8.4.2.1. Growing geriatric population to drive the market for cardiac mapping systems
    • 8.4.3. INDIA
      • 8.4.3.1. Increasing government initiatives towards healthcare are supporting the growth of the cardiac mapping systems market in India
    • 8.4.4. REST OF ASIA PACIFIC
  • 8.5. REST OF THE WORLD

9. COMPETITIVE LANDSCAPE

  • 9.1. INTRODUCTION
  • 9.2. MARKET RANKING ANALYSIS
  • 9.3. COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
    • 9.3.1. VISIONARY LEADERS
    • 9.3.2. INNOVATORS
    • 9.3.3. EMERGING COMPANIES
    • 9.3.4. DYNAMIC DIFFERENTIATORS
  • 9.4. COMPETITIVE SCENARIO
    • 9.4.1. PRODUCT LAUNCHES & APPROVALS
    • 9.4.2. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 9.4.3. ACQUISITIONS

10. COMPANY PROFILES (Business overview, Products offered, Recent developments, Competitive Analysis)*

  • 10.1. BIOSENSE WEBSTER, INC. (A JOHNSON & JOHNSON COMPANY)
  • 10.2. ABBOTT LABORATORIES
  • 10.3. BOSTON SCIENTIFIC CORPORATION
  • 10.4. MEDTRONIC PLC
  • 10.5. MICROPORT SCIENTIFIC CORPORATION
  • 10.6. EP SOLUTIONS SA
  • 10.7. ACUTUS MEDICAL
  • 10.8. KONINKLIJKE PHILIPS N.V.
  • 10.9. LEPU MEDICAL
  • 10.10. BIOTRONIK
  • 10.11. ANGIODYNAMICS
  • 10.12. BIOSIG TECHNOLOGIES, INC.
  • 10.13. APN HEALTH, LLC
  • 10.14. COREMAP
  • 10.15. KARDIUM, INC.
  • 10.16. CATHETER PRECISION, INC.
  • 10.17. EPMAP-SYSTEM

*Business overview, Products offered, Recent developments, Competitive Analysis might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3. AVAILABLE CUSTOMIZATIONS
  • 11.4. RELATED REPORTS
  • 11.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NEW ENTRANTS IN THE CARDIAC MAPPING SYSTEMS MARKET
  • TABLE 2: POPULATION STATISTICS, 2015 VS. 2030 VS. 2050 (MILLION INDIVIDUALS)
  • TABLE 3: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4: CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 5: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 6: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: APAC: ELECTROANATOMICAL MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: BASKET CATHETER MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: EUROPE: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: APAC: BASKET CATHETER MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NORTH AMERICA: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: EUROPE: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: APAC: TRADITIONAL ENDOCARDIAL CONTACT MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24: EUROPE: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: APAC: NON-CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 27: CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIAL FLUTTER, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 36: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA , BY REGION, 2017-2024 (USD MILLION)
  • TABLE 37: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: APAC: CARDIAC MAPPING SYSTEMS MARKET FOR ATRIOVENTRICULAR NODAL REENTRY TACHYCARDIA, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 41: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42: EUROPE: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: APAC: CARDIAC MAPPING SYSTEMS MARKET FOR OTHER ARRHYTHMIAS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 49: CLINICAL TRIALS RELATED TO CARDIAC MAPPING DEVICES
  • TABLE 50: US: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 51: US: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 52: US: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 53: RESEARCH GRANTS TOWARDS RESEARCH IN CARDIOLOGY
  • TABLE 54: CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 55: CANADA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 56: CANADA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 57: EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 59: EUROPE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60: EUROPE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 61: GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 62: GERMANY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63: GERMANY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 64: UK: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: UK: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66: UK: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 67: FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 68: FRANCE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69: FRANCE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 70: ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: ITALY: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 72: ITALY: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 73: SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74: SPAIN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 75: SPAIN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 76: CARDIAC AF ABLATION PROCEDURES, BY COUNTRY, 2015 VS. 2016
  • TABLE 77: ROE: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78: ROE: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: ROE: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 80: APAC: CARDIAC MAPPING SYSTEMS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 81: APAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 82: APAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 83: APAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 84: JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: JAPAN: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: JAPAN: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 87: CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 88: CHINA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89: CHINA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 90: INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: INDIA: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: INDIA: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 93: ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94: ROAPAC: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: ROAPAC: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 96: ROW: CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 97: ROW: CONTACT CARDIAC MAPPING SYSTEMS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: ROW: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2017-2024 (USD MILLION)
  • TABLE 99: RIGHT-TO-WIN
  • TABLE 100: PRODUCT LAUNCHES & APPROVALS (2017-2019)
  • TABLE 101: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2017-2019)
  • TABLE 102: ACQUISITIONS (2017-2019)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: CARDIAC MAPPING SYSTEMS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: CARDIAC MAPPING SYSTEMS MARKET SHARE, BY TYPE, 2019
  • FIGURE 7: CARDIAC MAPPING SYSTEMS MARKET, BY INDICATION, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MAPPING SYSTEMS MARKET
  • FIGURE 9: INCREASING INCIDENCE OF TARGET DISEASES AND ENTRY OF NEW PLAYERS TO DRIVE THE GROWTH OF THE MARKET
  • FIGURE 10: ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN CARDIAC MAPPING SYSTEMS MARKET IN 2019
  • FIGURE 11: CONTACT CARDIAC MAPPING SYSTEMS TO DOMINATE THE CARDIAC MAPPING SYSTEMS MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: ATRIAL FIBRILLATION TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
  • FIGURE 13: APAC TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 14: CARDIAC MAPPING SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: CARDIAC MAPPING SYSTEMS MARKET, BY REGION, 2019 VS. 2024
  • FIGURE 16: NORTH AMERICA: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
  • FIGURE 17: ASIA PACIFIC: CARDIAC MAPPING SYSTEMS MARKET SNAPSHOT
  • FIGURE 18: KEY DEVELOPMENTS IN THE CARDIAC MAPPING SYSTEMS MARKET, 2017-2019
  • FIGURE 19: CARDIAC MAPPING SYSTEMS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 20: CARDIAC MAPPING SYSTEMS MARKET COMPETITIVE LEADERSHIP MAPPING, 2018
  • FIGURE 21: ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 22: BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 23: MEDTRONIC PLC: COMPANY SNAPSHOT
  • FIGURE 24: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 25: KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 26: LEPU MEDICAL: COMPANY SNAPSHOT (2017)
  • FIGURE 27: ANGIODYNAMICS: COMPANY SNAPSHOT